Literature DB >> 29378721

Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort.

Marco Falcone1, Giusy Tiseo2, Emanuele Durante-Mangoni3, Veronica Ravasio4, Francesco Barbaro5, Maria Paola Ursi6, Maria Bruna Pasticci7, Matteo Bassetti8, Paolo Grossi9, Mario Venditti10, Marco Rizzi4.   

Abstract

The objective of this study was to investigate predisposing factors and outcomes of infective endocarditis (IE) caused by non-HACEK Gram-negative bacilli (GNB) in a contemporary multicenter cohort. Patients with IE due to GNB, prospectively observed in 26 Italian centers from 2004 to 2011, were analyzed. Using a case-control design, each case was compared to three age- and sex-matched controls with IE due to other etiologies. Logistic regression was performed to identify risk factors for IE due to GNB. Factors associated with early and late mortality were assessed by Cox regression analysis. The study group comprised 58 patients with IE due to GNB. We found that Escherichia coli was the most common pathogen, followed by Pseudomonas aeruginosa and Klebsiella pneumoniae The genitourinary tract as a source of infection (odds ratio [OR], 13.59; 95% confidence interval [CI], 4.63 to 39.93; P < 0.001), immunosuppression (OR, 5.16; 95% CI, 1.60 to 16.24; P = 0.006), and the presence of a cardiac implantable electronic device (CIED) (OR, 3.57; 95% CI, 1.55 to 8.20; P = 0.003) were factors independently associated with IE due to GNB. In-hospital mortality was 13.8%, and mortality rose to 30.6% at 1 year. A multidrug-resistant (MDR) etiology was associated with in-hospital mortality (hazard ratio [HR], 21.849; 95% CI, 2.672 to 178.683; P = 0.004) and 1-year mortality (HR, 4.408; 95% CI, 1.581 to 12.287; P = 0.005). We conclude that the presence of a genitourinary focus, immunosuppressive therapy, and an indwelling CIED are factors associated with IE due to GNB. MDR etiology is the major determinant of in-hospital and long-term mortality.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Gram-negative bacteria; infective endocarditis; multidrug resistance

Mesh:

Year:  2018        PMID: 29378721      PMCID: PMC5913980          DOI: 10.1128/AAC.02208-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years.

Authors:  Emanuele Durante-Mangoni; Roberto Andini; Federica Agrusta; Domenico Iossa; Irene Mattucci; Mariano Bernardo; Riccardo Utili
Journal:  Eur J Intern Med       Date:  2014-06-19       Impact factor: 4.487

2.  16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.

Authors:  Arnold J Greenspon; Jasmine D Patel; Edmund Lau; Jorge A Ochoa; Daniel R Frisch; Reginald T Ho; Behzad B Pavri; Steven M Kurtz
Journal:  J Am Coll Cardiol       Date:  2011-08-30       Impact factor: 24.094

3.  Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.

Authors:  S Leone; V Ravasio; E Durante-Mangoni; M Crapis; G Carosi; P G Scotton; N Barzaghi; M Falcone; P Chinello; M B Pasticci; P Grossi; R Utili; P Viale; M Rizzi; F Suter
Journal:  Infection       Date:  2012-06-19       Impact factor: 3.553

4.  Infections of cardiac implantable electronic devices: a retrospective multicenter observational study.

Authors:  George M Viola; Leah L Awan; Luis Ostrosky-Zeichner; Wenyaw Chan; Rabih O Darouiche
Journal:  Medicine (Baltimore)       Date:  2012-05       Impact factor: 1.889

5.  Identification of causative organism in cardiac implantable electronic device infections.

Authors:  Masato Fukunaga; Masahiko Goya; Michio Nagashima; Kenichi Hiroshima; Takashi Yamada; Yoshimori An; Kentaro Hayashi; Yu Makihara; Masatsugu Ohe; Kei Ichihashi; Morimasa Ohtsuka; Hiroaki Miyazaki; Kenji Ando
Journal:  J Cardiol       Date:  2017-04-25       Impact factor: 3.159

Review 6.  ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.

Authors:  E Tacconelli; M A Cataldo; S J Dancer; G De Angelis; M Falcone; U Frank; G Kahlmeter; A Pan; N Petrosillo; J Rodríguez-Baño; N Singh; M Venditti; D S Yokoe; B Cookson
Journal:  Clin Microbiol Infect       Date:  2014-01       Impact factor: 8.067

7.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Authors:  David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell
Journal:  Arch Intern Med       Date:  2009-03-09

8.  Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome.

Authors:  Paul Loubet; François-Xavier Lescure; Laurent Lepage; Matthias Kirsch; Laurence Armand-Lefevre; Lila Bouadma; Sylvie Lariven; Xavier Duval; Yazdan Yazdanpanah; Veronique Joly
Journal:  Infect Dis (Lond)       Date:  2015-08-11

9.  Non-HACEK gram-negative bacillus endocarditis.

Authors:  Susan Morpeth; David Murdoch; Christopher H Cabell; Adolf W Karchmer; Paul Pappas; Donald Levine; Francisco Nacinovich; Pierre Tattevin; Núria Fernández-Hidalgo; Stuart Dickerman; Emilio Bouza; Ana del Río; Tatjana Lejko-Zupanc; Auristela de Oliveira Ramos; Diana Iarussi; John Klein; Catherine Chirouze; Roger Bedimo; G Ralph Corey; Vance G Fowler
Journal:  Ann Intern Med       Date:  2007-12-18       Impact factor: 25.391

10.  Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI).

Authors:  Marco Rizzi; Veronica Ravasio; Alessandra Carobbio; Irene Mattucci; Massimo Crapis; Roberto Stellini; Maria Bruna Pasticci; Pierangelo Chinello; Marco Falcone; Paolo Grossi; Francesco Barbaro; Angelo Pan; Pierluigi Viale; Emanuele Durante-Mangoni
Journal:  BMC Infect Dis       Date:  2014-04-29       Impact factor: 3.090

View more
  20 in total

1.  A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam.

Authors:  Alessandra Iacovelli; Martina Spaziante; Samir Al Moghazi; Alessandra Giordano; Giancarlo Ceccarelli; Mario Venditti
Journal:  Infection       Date:  2018-06-20       Impact factor: 3.553

Review 2.  Infective endocarditis by Proteus species: a systematic review.

Authors:  Petros Ioannou; Georgios Vougiouklakis
Journal:  Germs       Date:  2020-09-01

3.  Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis.

Authors:  Ashley Lorenz; Mohammad Mahdee E Sobhanie; Libby Orzel; Kelci Coe; Lynn Wardlow
Journal:  Diagn Microbiol Infect Dis       Date:  2021-07-24       Impact factor: 2.803

4.  Infectious Endocarditis Caused by Pseudomona aeruginosa on Bicuspid Aortic Valve.

Authors:  Juan Lacalzada-Almeida; Maria Manuela Izquierdo-Gomez; Amelia Duque-Gonzalez; Maria Del Mar Alonso-Socas; Rebeca Munoz-Rodriguez
Journal:  J Med Cases       Date:  2022-06-11

Review 5.  Infective Endocarditis in the Elderly: Challenges and Strategies.

Authors:  Carlos Bea; Sara Vela; Sergio García-Blas; Jose-Angel Perez-Rivera; Pablo Díez-Villanueva; Ana Isabel de Gracia; Eladio Fuertes; Maria Rosa Oltra; Ana Ferrer; Andreu Belmonte; Enrique Santas; Mauricio Pellicer; Javier Colomina; Alberto Doménech; Vicente Bodi; Maria José Forner; Francisco Javier Chorro; Clara Bonanad
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-17

6.  Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam.

Authors:  Majed F Alghoribi; Moayad Alqurashi; Liliane Okdah; Bassam Alalwan; Yahya S AlHebaishi; Abdulmajeed Almalki; Maha A Alzayer; Abdulrahman A Alswaji; Michel Doumith; Mazin Barry
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

7.  Escherichia coli Endocarditis Presenting With Septic Shock in an Immunocompetent Female Patient.

Authors:  Christos Davoulos; Maria Lagadinou; Athanasios Moulias; Christos Triantos; Nikolaos Koutsogiannis; Markos Marangos; Stelios F Assimakopoulos
Journal:  Cardiol Res       Date:  2019-10-04

8.  Elusive Enterobacter cloacae causing pacemaker endocarditis.

Authors:  Naji Maaliki; Jorge Verdecia; Malleswari Ravi
Journal:  IDCases       Date:  2021-05-07

9.  Influence of the type of pathogen on the clinical course of infectious complications related to cardiac implantable electronic devices.

Authors:  Anna Polewczyk; Wojciech Jacheć; Luca Segreti; Maria Grazia Bongiorni; Andrzej Kutarski
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

10.  Expect the Unexpected: A Rare Case of Pseudomonas aerguinosa Endocarditis.

Authors:  Swetha Ramireddy; Smitha Gudipati; Marcus Zervos
Journal:  IDCases       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.